Abstract
Fragile X syndrome characterized by intellectual disability (ID), facial dysmorphism, and postpubertal macroorchidism is the most common monogenic cause of ID. It is typically induced by an expansion of a CGG repeat in the fragile X mental retardation 1 (FMR1) gene on Xq27 to more than 200 repeats. Only rarely patients have atypical mutations in the FMR1 gene such as point mutations, deletions, or unmethylated/partially methylated full mutations. Most of these patients show a minor phenotype or even appear clinically healthy. Here, we report the dysmorphism and clinical features of a 17-year-old boy with a partially methylated full mutation of approximately 250 repeats. Diagnosis was made subsequently to the evaluation of a FMR1 premutation as the cause for maternal premature ovarian failure. Dysmorphic evaluation revealed no strikingly long face, no prominent forehead/frontal bossing, no prominent mandible, no macroorchidism, and a head circumference in the lower normal range. Acquisition of a driving license for mopeds and unaccompanied rides by public transport in his home province indicate rather mild ID (IQ = 58). Conclusion: This adolescent demonstrates that apart from only minor ID, patients with a partially methylated FMR1 full mutation present less to absent pathognomonic facial dysmorphism, thus emphasizing the impact of family history for a straightforward clinical diagnosis.
Similar content being viewed by others
Abbreviations
- EEG:
-
Electroencephalogram
- FMR1:
-
Fragile X mental retardation 1
- ID:
-
Intellectual disability
- OFC:
-
Occipitofrontal head circumference
- VMI:
-
Developmental Test of Visual-Motor Integration
- WISC-IV:
-
Wechsler Intelligence Scale for Children-IV
References
Beery K (2007) Developmental test of visual-motor integration VMI. Modern Curriculum Press, New Jersey
Coffee B, Keith K, Albizua I, Malone T, Mowrey J, Sherman SL, Warren ST (2009) Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet 85(4):503–514
Giangreco CA, Steele MW, Aston CE, Cummins JH, Wenger SL (1996) A simplified six-item checklist for screening for fragile X syndrome in the pediatric population. J Pediatr 129(4):611–614
Guruju MR, Lavanya K, Thelma BK, Sujatha M, OmSai VR, Nagarathna V, Amarjyothi P, Jyothi A, Anandaraj MP (2009) Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India. J Clin Neurosci 16(10):1305–1310
Hagerman RJ, Amiri K, Cronister A (1991) Fragile X checklist. Am J Med Genet 38(2–3):283–287
Hagerman RJ, Hull CE, Safanda JF, Carpenter I, Staley LW, O’Connor RA, Seydel C, Mazzocco MM, Snow K, Thibodeau SN, Kuhl D, Nelson DL, Caskey CT, Taylor AK (1994) High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet 51(4):298–308
Lachiewicz AM, Dawson DV, Spiridigliozzi GA (2000) Physical characteristics of young boys with fragile X syndrome: reasons for difficulties in making a diagnosis in young males. Am J Med Genet 92(4):229–236
Lachiewicz AM, Spiridigliozzi GA, McConkie-Rosell A, Burgess D, Feng Y, Warren ST, Tarleton J (1996) A fragile X male with a broad smear on Southern blot analysis representing 100–500 CGG repeats and no methylation at the EagI site of the FMR-1 gene. Am J Med Genet 64(2):278–282
Laing S, Partington M, Robinson H, Turner G (1991) Clinical screening score for the fragile X (Martin-Bell) syndrome. Am J Med Genet 38(2–3):256–259
Loesch DZ, Huggins R, Hay DA, Gedeon AK, Mulley JC, Sutherland GR (1993) Genotype-phenotype relationships in fragile X syndrome: a family study. Am J Hum Genet 53(5):1064–1073
Loesch DZ, Sherwell S, Kinsella G, Tassone F, Taylor A, Amor D, Sung S, Evans A (2012) Fragile X-associated tremor/ataxia phenotype in a male carrier of unmethylated full mutation in the FMR1 gene. Clin Genet 82(1):88–92
McConkie-Rosell A, Lachiewicz AM, Spiridigliozzi GA, Tarleton J, Schoenwald S, Phelan MC, Goonewardena P, Ding X, Brown WT (1993) Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome. Am J Hum Genet 53(4):800–809
Merenstein SA, Shyu V, Sobesky WE, Staley L, Berry-Kravis E, Nelson DL, Lugenbeel KA, Taylor AK, Pennington BF, Hagerman RJ (1994) Fragile X syndrome in a normal IQ male with learning and emotional problems. J Am Acad Child Adolesc Psychiatry 33(9):1316–1321
Michelson DJ, Shevell MI, Sherr EH, Moeschler JB, Gropman AL, Ashwal S (2011) Evidence report: genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 77(17):1629–1635
Petermann F, Petermann U (2008) Wechsler Intelligence Scale for Children IV (WISC-IV). Hogrefe, Göttingen
Rodriguez-Revenga L, Madrigal I, Pagonabarraga J, Xunclà M, Badenas C, Kulisevsky J, Gomez B, Milà M (2009) Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur J Hum Genet 17(10):1359–1362
Rousseau F, Heitz D, Biancalana V, Blumenfeld S, Kretz C, Boué J, Tommerup N, Van Der Hagen C, DeLozier-Blanchet C, Croquette MF, Gilgenkrantz S, Jalbert P, Voelkel M-A, Oberle I, Mandel JL (1991) Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med 325(24):1673–1681
Rousseau F, Robb LJ, Rouillard P, Der Kaloustian VM (1994) No mental retardation in a man with 40% abnormal methylation at the FMR-1 locus and transmission of sperm cell mutations as premutations. Hum Mol Genet 3(6):927–930
Russo S, Briscioli V, Cogliati F, Macchi M, Lalatta F, Larizza L (1998) An unusual fragile X sibship: female compound heterozygote and male with a partially methylated full mutation. Clin Genet 54(4):309–314
Sherman S, Pletcher BA, Driscoll DA (2005) Fragile X syndrome: diagnostic and carrier testing. Genet Med 7(8):584–587
Sherr EH, Michelson DJ, Shevell MI, Moeschler JB, Gropman AL, Ashwal S (2013) Neurodevelopmental disorders and genetic testing: current approaches and future advances. Ann Neurol 74:164–170
Smeets HJ, Smits AP, Verheij CE, Theelen JP, Willemsen R, van de Burgt I, Hoogeveen AT, Oosterwijk JC, Oostra BA (1995) Normal phenotype in two brothers with a full FMR1 mutation. Hum Mol Genet 4(11):2103–2108
Sorensen PL, Basuta K, Mendoza-Morales G, Gane LW, Schneider A, Hagerman R, Tassone F (2012) A fragile X sibship from a consanguineous family with a compound heterozygous female and partially methylated full mutation male. Am J Med Genet 158A(5):1221–1224
Steyaert J, Borghgraef M, Legius E, Fryns JP (1996) Molecular-intelligence correlations in young fragile X males with a mild CGG repeat expansion in the FMR1 gene. Am J Med Genet 64(2):274–277
Tabolacci E, Moscato U, Zalfa F, Bagni C, Chiurazzi P, Neri G (2008) Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations. Eur J Hum Genet 16(12):1487–1498
Tassone F, Hagerman RJ, Iklé DN, Dyer PN, Lampe M, Willemsen R, Oostra BA, Taylor AK (1999) FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet 84(3):250–261
Tassone F, Hagerman RJ, Loesch DZ, Lachiewicz A, Taylor AK, Hagerman PJ (2000) Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am J Med Genet 94(3):232–236
Taylor AK, Tassone F, Dyer PN, Hersch SM, Harris JB, Greenough WT, Hagerman RJ (1999) Tissue heterogeneity of the FMR1 mutation in a high-functioning male with fragile X syndrome. Am J Med Genet 84(3):233–239
Verkerk AJMH, Pieretti M, Sutcliffe JS, Fu Y-H, Kuhl DPA, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang F, Eussen BE, van Ommen G-JB, Blonden LAJ, Riggins GJ, Chastain JL, Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA, Warren ST (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905–991
Wang Z, Taylor AK, Bridge JA (1996) FMR1 fully expanded mutation with minimal methylation in a high functioning fragile X male. J Med Genet 33(5):376–378
Wöhrle D, Salat U, Gläser D, Mücke J, Meisel-Stosiek M, Schindler D, Vogel W, Steinbach P (1998) Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats. J Med Genet 35(2):103–111
Acknowledgments
We thank the patient and his family for their support of this publication and Konrad Schmidt for his editorial help.
Conflict of interest
None of the authors has any conflict of interest. All authors have seen and approved the manuscript. No payment was given to anyone to produce the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Beat Steinmann
The manuscript has not been and will not be submitted elsewhere while it is under consideration of the European Journal of Pediatrics. The first draft of the manuscript was written by the first authors.
Rights and permissions
About this article
Cite this article
Haberlandt, E., Zotter, S., Witsch-Baumgartner, M. et al. Don’t miss patients with atypical FMR1 mutations: dysmorphism and clinical features in a boy with a partially methylated FMR1 full mutation. Eur J Pediatr 173, 1257–1261 (2014). https://doi.org/10.1007/s00431-014-2375-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-014-2375-6